Evidence map›Paper›PMID 31090940›Full record

ArticleHepatology (Baltimore, Md.)2019

Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease.

Mrigya Babuta, Istvan Furi, Shashi Bala, Terence N Bukong, Patrick Lowe, Donna Catalano, Charles Calenda, Karen Kodys, Gyongyi Szabo

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 213 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Autophagy in the liver.Autophagy reports · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. mTOR Signaling in Macrophages: All Depends on the Context.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mrigya BabutaDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Istvan FuriDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Shashi BalaDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Terence N BukongDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Patrick LoweDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Donna CatalanoDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Charles CalendaDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Karen KodysDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
Gyongyi SzaboDepartment of Medicine, University of Massachusetts Medical School, Worcester, MA.
University of Massachusetts Chan Medical School · US

Funding

Alcohol and Monocyte Signaling Administrative SupplementR01AA011576 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Gyongyi Szabo · 1998 to 2026
$9.3M
Novel Therapies for Alcoholic HepatitisU01AA021893 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI MCCLAIN, CRAIG J., MCCULLOUGH, ARTHUR JOSEPH · 2012 to 2017
$6.0M
MicroRNAs in Alcoholic Liver Disease Administrative SupplementR01AA020744 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2011 to 2023
$5.3M
TLR4 Signaling in alcoholic liver diseaseR01AA017729 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2009 to 2021
$4.3M
Novel Therapies in alcoholic hepatitis - UMMS Translational ProgramU01AA021907 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2012 to 2017
$2.0M
Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 4/9U01AA026977 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2018 to 2022
$1.8M
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical DiscoveryUH3AA026970 · NIAAA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SZABO, GYONGYI · 2020 to 2022
$1.3M
Extracellular Vesicles in Alcoholic Liver Disease: Basic and Pre-Clinical DiscoveryUH2AA026970 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2018 to 2019
$461k
NIAAA NIH HHS R01 AA011576NIAAA NIH HHS R01 AA017729NIAAA NIH HHS R01 AA020744NIAAA NIH HHS U01 AA021893NIAAA NIH HHS U01 AA021907NIAAA NIH HHS U01 AA026977NIAAA NIH HHS UH2 AA026970NIAAA NIH HHS UH3 AA026970
6 · The paper itself

Abstract

Cellular homeostais, that is normally maintained through autophagy, is disrupted in alcoholic liver disease (ALD). Because autophagy and exosome biogenesis share common elements, we hypothesized that increased exosome production in ALD may be linked to disruption of autophagic function. We found impaired autophagy both in ALD and alcoholic hepatitis (AH) mouse models and human livers with ALD as indicated by increased hepatic p62 and LC3-II levels. Alcohol reduced autophagy flux in vivo in chloroquine-treated mice as well as in vitro in hepatocytes and macrophages treated with bafilomycin A. Our results revealed that alcohol targets multiple steps in the autophagy pathway. Alcohol-related decrease in mechanistic target of rapamycin (mTOR) and Ras homolog enriched in brain (Rheb), that initiate autophagy, correlated with increased Beclin1 and autophagy-related protein 7 (Atg7), proteins involved in phagophore-autophagosome formation, in ALD. We found that alcohol disrupted autophagy function at the lysosomal level through decreased lysosomal-associated membrane protein 1 (LAMP1) and lysosomal-associated membrane protein 2 (LAMP2) in livers with ALD. We identified that micro-RNA 155 (miR-155), that is increased by alcohol, targets mTOR, Rheb, LAMP1, and LAMP2 in the authophagy pathway. Consistent with this, miR-155-deficient mice were protected from alcohol-induced disruption of autophagy and showed attenuated exosome production. Mechanistically, down-regulation of LAMP1 or LAMP2 increased exosome release in hepatocytes and macrophages in the presence and absence of alcohol. These results suggested that the alcohol-induced increase in exosome production was linked to disruption of autophagy and impaired autophagosome and lysosome function. Conclusion: Alcohol affects multiple genes in the autophagy pathway and impairs autophagic flux at the lysosome level in ALD. Inhibition of LAMP1 and LAMP2 promotes exosome release in ALD. We identified miR-155 as a mediator of alcohol-related regulation of autophagy and exosome production in hepatocytes and macrophages.

Indexed as

AnimalsAutophagyExosomesFemaleHepatitis, AlcoholicHepatocytesHumansLiver Diseases, AlcoholicLysosomal-Associated Membrane Protein 1Lysosomal-Associated Membrane Protein 2LysosomesMacrophagesMiceMice, Inbred C57BLMicroRNAsMicrotubule-Associated ProteinsLysosomal-Associated Membrane Protein 1Lysosomal-Associated Membrane Protein 2MAP1LC3B protein, humanMicroRNAsMicrotubule-Associated ProteinsMIRN155 microRNA, humanP62 protein, humanRNA-Binding ProteinsTOR Serine-Threonine Kinases

Identifiers

PMID31090940
PMCPMC7453183
OpenAlexW2946735701

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.